{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:49:53Z","timestamp":1760820593662,"version":"3.37.3"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T00:00:00Z","timestamp":1398643200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1038\/bmt.2014.91","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T13:41:57Z","timestamp":1398692517000},"page":"1076-1083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Activated MHC-mismatched T helper-1 lymphocyte infusion enhances GvL with limited GvHD"],"prefix":"10.1038","volume":"49","author":[{"given":"Y","family":"Zeng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Stokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-6965","authenticated-orcid":false,"given":"E","family":"Katsanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,28]]},"reference":[{"issue":"Pt 1","key":"BFbmt201491_CR1","first-page":"248","volume":"13","author":"PL Weiden","year":"1981","unstructured":"Weiden PL, Flournoy N, Sanders JE, Sullivan KM, Thomas ED . Antileukemic effect of graft-versus-host disease contributes to improved survival after allogeneic marrow transplantation. Transplant Proc 1981; 13 (Pt 1): 248\u2013251.","journal-title":"Transplant Proc"},{"key":"BFbmt201491_CR2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555\u2013562.","journal-title":"Blood"},{"key":"BFbmt201491_CR3","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0140-6736(84)92009-9","volume":"2","author":"RP Gale","year":"1984","unstructured":"Gale RP, Champlin RE . How does bone-marrow transplantation cure leukaemia? Lancet 1984; 2: 28\u201330.","journal-title":"Lancet"},{"key":"BFbmt201491_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.7326\/0003-4819-120-8-199404150-00004","volume":"120","author":"RP Gale","year":"1994","unstructured":"Gale RP, Horowitz MM, Ash RC, Champlin RE, Goldman JM, Rimm AA et al. Identical-twin bone marrow transplants for leukemia. Ann Int Med 1994; 120: 646\u2013652.","journal-title":"Ann Int Med"},{"key":"BFbmt201491_CR5","doi-asserted-by":"publisher","first-page":"6963","DOI":"10.1182\/blood-2011-01-332007","volume":"117","author":"RJ Soiffer","year":"2011","unstructured":"Soiffer RJ, Lerademacher J, Ho V, Kan F, Artz A, Champlin RE et al. Impact of immune modulation with anti-T-cell antibodies on the outcome of reduced-intensity allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Blood 2011; 117: 6963\u20136970.","journal-title":"Blood"},{"key":"BFbmt201491_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1046\/j.1365-2141.2003.04612.x","volume":"123","author":"S D'Sa","year":"2003","unstructured":"D'Sa S, Peggs K, Pizzey A, Verfuerth S, Thuraisundaram D, Watts M et al. T- and B-cell immune reconstitution and clinical outcome in patients with multiple myeloma receiving T-cell-depleted, reduced-intensity allogeneic stem cell transplantation with an alemtuzumab-containing conditioning regimen followed by escalated donor lymphocyte infusions. Br J Haematol 2003; 123: 309\u2013322.","journal-title":"Br J Haematol"},{"key":"BFbmt201491_CR7","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1053\/j.seminoncol.2012.09.004","volume":"39","author":"JP Bastien","year":"2012","unstructured":"Bastien JP, Roy J, Roy DC . Selective T-cell depletion for haplotype-mismatched allogeneic stem cell transplantation. Semin Oncol 2012; 39: 674\u2013682.","journal-title":"Semin Oncol"},{"key":"BFbmt201491_CR8","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/bmt.2011.237","volume":"47","author":"K Perruccio","year":"2012","unstructured":"Perruccio K, Topini F, Tosti A, Carotti A, Burchielli E, Ruggeri L et al. Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. Bone Marrow Transplant 2012; 47: 1196\u20131200.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201491_CR9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1182\/blood-2006-02-001909","volume":"108","author":"PJ Amrolia","year":"2006","unstructured":"Amrolia PJ, Muccioli-Casadei G, Huls H, Adams S, Durett A, Gee A et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006; 108: 1797\u20131808.","journal-title":"Blood"},{"key":"BFbmt201491_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.bbmt.2012.10.004","volume":"19","author":"N Askenasy","year":"2013","unstructured":"Askenasy N, Mizrahi K, Ash S, Askenasy EM, Yaniv I, Stein J . Depletion of naive lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity. Biol Blood Marrow Transplant 2013; 19: 185\u2013195.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201491_CR11","doi-asserted-by":"publisher","first-page":"4129","DOI":"10.1182\/blood-2013-08-519413","volume":"122","author":"JN Kochenderfer","year":"2013","unstructured":"Kochenderfer JN, Dudley ME, Carpenter RO, Kassim SH, Rose JJ, Telford WG et al. Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood 2013; 122: 4129\u20134139.","journal-title":"Blood"},{"key":"BFbmt201491_CR12","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V76.12.2462.2462","volume":"76","author":"HJ Kolb","year":"1990","unstructured":"Kolb HJ, Mittermuller J, Clemm C, Holler E, Ledderose G, Brehm G et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 76: 2462\u20132465.","journal-title":"Blood"},{"key":"BFbmt201491_CR13","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","volume":"86","author":"HJ Kolb","year":"1995","unstructured":"Kolb HJ, Schattenberg A, Goldman JM, Hertenstein B, Jacobsen N, Arcese W et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood 1995; 86: 2041\u20132050.","journal-title":"Blood"},{"key":"BFbmt201491_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/bmt.2008.259","volume":"42","author":"M Tomblyn","year":"2008","unstructured":"Tomblyn M, Lazarus HM . Donor lymphocyte infusions: the long and winding road: how should it be traveled? Bone Marrow Transplant 2008; 42: 569\u2013579.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201491_CR15","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.leukres.2008.05.007","volume":"32","author":"M Har-Noy","year":"2008","unstructured":"Har-Noy M, Zeira M, Weiss L, Slavin S . Completely mismatched allogeneic CD3\/CD28 cross-linked Th1 memory cells elicit anti-leukemia effects in unconditioned hosts without GVHD toxicity. Leuk Res 2008; 32: 1903\u20131913.","journal-title":"Leuk Res"},{"key":"BFbmt201491_CR16","first-page":"1068","volume":"26","author":"M Zeis","year":"1998","unstructured":"Zeis M, Uharek L, Glass B, Vosskotter W, Dreger P, Schmitz N et al. Eradication of residual disease by administration of leukemia-specific T cells after experimental allogeneic bone marrow transplantation. Exp Hematol 1998; 26: 1068\u20131073.","journal-title":"Exp Hematol"},{"key":"BFbmt201491_CR17","doi-asserted-by":"publisher","first-page":"G764","DOI":"10.1152\/ajpgi.2001.281.3.G764","volume":"281","author":"A Burich","year":"2001","unstructured":"Burich A, Hershberg R, Waggie K, Zeng W, Brabb T, Westrich G et al. Helicobacter-induced inflammatory bowel disease in IL-10- and T cell-deficient mice. Am J Physiol Gastrointest Liver Physiol 2001; 281: G764\u2013G778.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFbmt201491_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/PL00006680","volume":"50","author":"L He","year":"2001","unstructured":"He L, Feng H, Raymond A, Kreeger M, Zeng Y, Graner M et al. Dendritic-cell-peptide immunization provides immunoprotection against bcr-abl-positive leukemia in mice. Cancer Immunol Immunother 2001; 50: 31\u201340.","journal-title":"Cancer Immunol Immunother"},{"key":"BFbmt201491_CR19","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood-2010-06-288621","volume":"117","author":"N Janikashvili","year":"2011","unstructured":"Janikashvili N, LaCasse CJ, Larmonier C, Trad M, Herrell A, Bustamante S et al. Allogeneic effector\/memory Th-1 cells impair FoxP3+ regulatory T lymphocytes and synergize with chaperone-rich cell lysate vaccine to treat leukemia. Blood 2011; 117: 1555\u20131564.","journal-title":"Blood"},{"key":"BFbmt201491_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.leukres.2008.08.017","volume":"33","author":"M Har-Noy","year":"2009","unstructured":"Har-Noy M, Zeira M, Weiss L, Fingerut E, Or R, Slavin S . Allogeneic CD3\/CD28 cross-linked Th1 memory cells provide potent adjuvant effects for active immunotherapy of leukemia\/lymphoma. Leuk Res 2009; 33: 525\u2013538.","journal-title":"Leuk Res"},{"key":"BFbmt201491_CR21","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.4049\/jimmunol.143.11.3503","volume":"143","author":"M Sykes","year":"1989","unstructured":"Sykes M, Chester CH, Sundt TM, Romick ML, Hoyles KA, Sachs DH . Effects of T cell depletion in radiation bone marrow chimeras. III. Characterization of allogeneic bone marrow cell populations that increase allogeneic chimerism independently of graft-vs-host disease in mixed marrow recipients. J Immunol 1989; 143: 3503\u20133511.","journal-title":"J Immunol"},{"key":"BFbmt201491_CR22","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1172\/JCI17601","volume":"112","author":"BE Anderson","year":"2003","unstructured":"Anderson BE, McNiff J, Yan J, Doyle H, Mamula M, Shlomchik MJ et al. Memory CD4+ T cells do not induce graft-versus-host disease. J Clin Invest 2003; 112: 101\u2013108.","journal-title":"J Clin Invest"},{"key":"BFbmt201491_CR23","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2003-08-2987","volume":"103","author":"BJ Chen","year":"2004","unstructured":"Chen BJ, Cui X, Sempowski GD, Liu C, Chao NJ . Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 2004; 103: 1534\u20131541.","journal-title":"Blood"},{"key":"BFbmt201491_CR24","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1182\/blood-2007-08-109678","volume":"111","author":"H Zheng","year":"2008","unstructured":"Zheng H, Matte-Martone C, Li H, Anderson BE, Venketesan S, Sheng Tan H et al. Effector memory CD4+ T cells mediate graft-versus-leukemia without inducing graft-versus-host disease. Blood 2008; 111: 2476\u20132484.","journal-title":"Blood"},{"key":"BFbmt201491_CR25","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1182\/blood-2004-12-4726","volume":"105","author":"CA Wysocki","year":"2005","unstructured":"Wysocki CA, Panoskaltsis-Mortari A, Blazar BR, Serody JS . Leukocyte migration and graft-versus-host disease. Blood 2005; 105: 4191\u20134199.","journal-title":"Blood"},{"key":"BFbmt201491_CR26","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1084\/jem.20060376","volume":"203","author":"R Chakraverty","year":"2006","unstructured":"Chakraverty R, Cote D, Buchli J, Cotter P, Hsu R, Zhao G et al. An inflammatory checkpoint regulates recruitment of graft-versus-host reactive T cells to peripheral tissues. J Exp Med 2006; 203: 2021\u20132031.","journal-title":"J Exp Med"},{"key":"BFbmt201491_CR27","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbmt.2006.02.005","volume":"12","author":"MY Mapara","year":"2006","unstructured":"Mapara MY, Leng C, Kim YM, Bronson R, Lokshin A, Luster A et al. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. Biol Blood Marrow Transplant 2006; 12: 623\u2013634.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201491_CR28","first-page":"2052","volume":"8","author":"E Zorn","year":"2002","unstructured":"Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ et al. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells. Clin Cancer Res 2002; 8: 2052\u20132060.","journal-title":"Clin Cancer Res"},{"key":"BFbmt201491_CR29","first-page":"437","volume":"3","author":"PJ Martin","year":"1988","unstructured":"Martin PJ, Hansen JA, Torok-Storb B, Moretti L, Press O, Storb R et al. Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease. Bone Marrow Transplant 1988; 3: 437\u2013444.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201491_CR30","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1182\/blood.V78.8.2120.2120","volume":"78","author":"AM Marmont","year":"1991","unstructured":"Marmont AM, Horowitz MM, Gale RP, Sobocinski K, Ash RC, van Bekkum DW et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120\u20132130.","journal-title":"Blood"},{"key":"BFbmt201491_CR31","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1182\/blood.V74.6.2227.2227","volume":"74","author":"NA Kernan","year":"1989","unstructured":"Kernan NA, Bordignon C, Heller G, Cunningham I, Castro-Malaspina H, Shank B et al. Graft failure after T-cell-depleted human leukocyte antigen identical marrow transplants for leukemia: I. Analysis of risk factors and results of secondary transplants. Blood 1989; 74: 2227\u20132236.","journal-title":"Blood"},{"key":"BFbmt201491_CR32","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/BF01644010","volume":"17","author":"T Schmeiser","year":"1989","unstructured":"Schmeiser T, Wiesneth M, Bunjes D, Arnold R, Hertenstein B, Heit W et al. Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow. Infection 1989; 17: 124\u2013130.","journal-title":"Infection"},{"key":"BFbmt201491_CR33","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1200\/JCO.1992.10.7.1191","volume":"10","author":"RJ Soiffer","year":"1992","unstructured":"Soiffer RJ, Murray C, Mauch P, Anderson KC, Freedman AS, Rabinowe SN et al. Prevention of graft-versus-host disease by selective depletion of CD6-positive T lymphocytes from donor bone marrow. J Clin Oncol 1992; 10: 1191\u20131200.","journal-title":"J Clin Oncol"},{"key":"BFbmt201491_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(05)66996-6","volume":"366","author":"JE Wagner","year":"2005","unstructured":"Wagner JE, Thompson JS, Carter SL, Kernan NA . Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial. Lancet 2005; 366: 733\u2013741.","journal-title":"Lancet"},{"key":"BFbmt201491_CR35","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1182\/blood-2007-06-093880","volume":"110","author":"AA Jakubowski","year":"2007","unstructured":"Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC et al. T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin. Blood 2007; 110: 4552\u20134559.","journal-title":"Blood"},{"key":"BFbmt201491_CR36","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1073\/pnas.0813335106","volume":"106","author":"GJ Tsao","year":"2009","unstructured":"Tsao GJ, Allen JA, Logronio KA, Lazzeroni LC, Shizuru JA . Purified hematopoietic stem cell allografts reconstitute immunity superior to bone marrow. Proc Natl Acad Sci USA 2009; 106: 3288\u20133293.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt201491_CR37","doi-asserted-by":"publisher","first-page":"14721","DOI":"10.1073\/pnas.1009220107","volume":"107","author":"AM Muller","year":"2010","unstructured":"Muller AM, Linderman JA, Florek M, Miklos D, Shizuru JA . Allogeneic T cells impair engraftment and hematopoiesis after stem cell transplantation. Proc Natl Acad Sci USA 2010; 107: 14721\u201314726.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbmt201491_CR38","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood-2012-05-432906","volume":"121","author":"AM de Bruin","year":"2013","unstructured":"de Bruin AM, Demirel O, Hooibrink B, Brandts CH, Nolte MA . Interferon-gamma impairs proliferation of hematopoietic stem cells in mice. Blood 2013; 121: 3578\u20133585.","journal-title":"Blood"},{"key":"BFbmt201491_CR39","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1182\/blood.V79.10.2628.2628","volume":"79","author":"C Caux","year":"1992","unstructured":"Caux C, Moreau I, Saeland S, Banchereau J . Interferon-gamma enhances factor-dependent myeloid proliferation of human CD34+ hematopoietic progenitor cells. Blood 1992; 79: 2628\u20132635.","journal-title":"Blood"},{"key":"BFbmt201491_CR40","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1182\/blood.V77.10.2118.2118","volume":"77","author":"Y Kawano","year":"1991","unstructured":"Kawano Y, Takaue Y, Hirao A, Abe T, Saito S, Matsunaga K et al. Synergistic effect of recombinant interferon-gamma and interleukin-3 on the growth of immature human hematopoietic progenitors. Blood 1991; 77: 2118\u20132121.","journal-title":"Blood"},{"issue":"Suppl 1","key":"BFbmt201491_CR41","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.bbmt.2007.10.021","volume":"14","author":"P Reddy","year":"2008","unstructured":"Reddy P, Negrin R, Hill GR . Mouse models of bone marrow transplantation. Biol Blood Marrow Transplant 2008; 14 (Suppl 1): 129\u2013135.","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201491","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201491.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T12:41:15Z","timestamp":1689165675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,28]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["BFbmt201491"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2014.91","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"type":"print","value":"0268-3369"},{"type":"electronic","value":"1476-5365"}],"subject":[],"published":{"date-parts":[[2014,4,28]]},"assertion":[{"value":"23 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}